Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CAPECITABINE Cause Myocardial infarction? 262 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 262 reports of Myocardial infarction have been filed in association with CAPECITABINE (Capecitabine). This represents 0.4% of all adverse event reports for CAPECITABINE.

262
Reports of Myocardial infarction with CAPECITABINE
0.4%
of all CAPECITABINE reports
59
Deaths
118
Hospitalizations

How Dangerous Is Myocardial infarction From CAPECITABINE?

Of the 262 reports, 59 (22.5%) resulted in death, 118 (45.0%) required hospitalization, and 25 (9.5%) were considered life-threatening.

Is Myocardial infarction Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CAPECITABINE. However, 262 reports have been filed with the FAERS database.

What Other Side Effects Does CAPECITABINE Cause?

Diarrhoea (9,277) Nausea (6,248) Palmar-plantar erythrodysaesthesia syndrome (5,294) Fatigue (5,018) Death (4,422) Vomiting (4,111) Disease progression (3,808) Off label use (3,193) Malignant neoplasm progression (2,425) Asthenia (2,352)

What Other Drugs Cause Myocardial infarction?

ROSIGLITAZONE (17,018) TESTOSTERONE (3,396) ADALIMUMAB (3,214) SACUBITRIL\VALSARTAN (3,120) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (2,391) APIXABAN (2,010) TICAGRELOR (1,749) LENALIDOMIDE (1,712) ETANERCEPT (1,693) METFORMIN\ROSIGLITAZONE (1,640)

Which CAPECITABINE Alternatives Have Lower Myocardial infarction Risk?

CAPECITABINE vs CAPIVASERTIB CAPECITABINE vs CAPLACIZUMAB CAPECITABINE vs CAPLACIZUMAB-YHDP CAPECITABINE vs CAPMATINIB CAPECITABINE vs CAPREOMYCIN

Related Pages

CAPECITABINE Full Profile All Myocardial infarction Reports All Drugs Causing Myocardial infarction CAPECITABINE Demographics